De Novo Protein Sequencing Applications and Challenges
De novo protein sequencing is a method used to determine the primary structure of proteins directly from experimental data without relying on genomic or protein database references. In proteomics research, de novo protein sequencing plays a crucial role, especially in identifying novel or post-translationally modified proteins from non-model organisms or unknown protein sources, offering indispensable insights. Unlike traditional protein identification methods, which depend on pre-existing protein databases, de novo sequencing bypasses these constraints, enabling the discovery of amino acid sequences absent from known databases. This capability makes it an invaluable tool in fields such as biomedicine, drug development, food safety, and environmental science. For instance, in the biopharmaceutical industry, de novo protein sequencing ensures the structural accuracy and consistency of protein-based therapeutics, which is vital for their efficacy and safety. In food science and agriculture, it enables the identification of allergenic proteins and novel allergens, forming the foundation for enhanced food safety assessments. In environmental studies, de novo sequencing aids in analyzing microbial proteomes, uncovering their ecological roles and functional contributions.
The core principle of de novo protein sequencing relies on mass spectrometry (MS) to resolve amino acid sequences. The workflow typically involves sample preparation, mass spectrometry analysis, data processing, and sequence assembly. In sample preparation, proteins are enzymatically digested and chemically modified to enhance mass spectrometry efficiency. During mass spectrometry analysis, high-resolution MS instruments generate spectra that contain detailed fragment ion data, essential for sequence deduction. In the data processing stage, spectra are carefully analyzed to remove noise and correct peak alignment, ensuring high-quality peptide mass data. Using specialized bioinformatics software, these peptide fragments are assembled into complete amino acid sequences.
The primary advantage of de novo protein sequencing lies in its independence from existing genomic or protein databases, making it uniquely suited for studying unexplored species and unknown protein structures. Furthermore, it excels in detecting post-translational modifications (PTMs) such as phosphorylation and glycosylation, offering deeper insights into protein functionality. Nevertheless, de novo protein sequencing presents challenges. Its accuracy heavily depends on mass spectrometry data quality and data processing efficiency. In complex samples, incomplete peptide coverage may lead to information gaps. Additionally, the similarity in mass between certain amino acid residues can cause ambiguities in sequence interpretation.
At MtoZ Biolabs, we specialize in delivering high-quality de novo protein sequencing services. With extensive experience, state-of-the-art mass spectrometry platforms, and advanced data analysis algorithms, our team ensures precise and reliable protein sequencing results. Partnering with MtoZ Biolabs provides access to comprehensive proteomics solutions, driving progress in both research and industrial applications.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
